The pharma company had reported a net profit of ₹517.9 crore in the corresponding period of the preceding fiscal. Natco Pharma on Friday posted a 60.8 per cent decline in consolidated net profit to ₹202.6 crore during the September quarter, weighed down by a fall in revenues.The pharma company had reported a net profit of ₹517.9 crore in the corresponding period of the preceding fiscal.Its revenue from operations declined to ₹967.